PUBLICATIONS · 1941054
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1991 Nov
- First author
- Thigpen JT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 1992 Aug;10(8):1365-6. doi: 10.1200/JCO.1992.10.8.1365.
- note
- Source null
- related pmid
- 1634928
- relationship
- Comment in
Authors and identifiers
- name
- Thigpen JT
- type
- Author
- name
- Blessing JA
- type
- Author
- name
- Beecham J
- type
- Author
- name
- Homesley H
- type
- Author
- name
- Yordan E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Thigpen JT
- type
- Author
- name
- Blessing JA
- type
- Author
- name
- Beecham J
- type
- Author
- name
- Homesley H
- type
- Author
- name
- Yordan E
- type
- Author
- bibliography ids
- nci-bib-7c62c59b4ed84a9b0d079e26
- book metadata
- content sha256
- 74a02b8bb1940c0771e829fb224fc5c72c9af6b6b368de8e64543863ec576895
- document type
- citation
- dois
- 10.1200/JCO.1991.9.11.1962
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:1941054
- immutable id
- pubmed:1941054@74a02b8bb1940c0771e829fb224fc5c72c9af6b6b368de8e64543863ec576895
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 11
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1962-6
- volume
- 9
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 1992 Aug;10(8):1365-6. doi: 10.1200/JCO.1992.10.8.1365.
- note
- Source null
- related pmid
- 1634928
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 1941054
- provenance
- batch id
- a86a47b66cb510ab0246
- provider
- NCBI PubMed ESummary
- record sha256
- 59624315d35de0625515042c738e6a6e51b5cd51e7b00e581ffa7226f76050db
- response sha256
- 62fa1bbcbdc25a5665b7097f6b22fc4289465701bcd0c8efaebd75831ecd761d
- retrieved at
- 2026-09-09T23:45:08.918507+00:00
- publication date
- display
- 1991 Nov
- precision
- month
- year
- 1991
- publication types
- Clinical Trial
- Journal Article
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/1941054/
- title
- Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
Preserved source evidence · Not medical advice
Triangle